Evidence map›Paper›PMID 20352468›Full record

ArticleCellular and molecular life sciences : CMLS2010

Transcription factor-based modulation of neural stem cell differentiation using direct protein transduction.

Kristin Stock, Lars Nolden, Frank Edenhofer, Tamara Quandel, Oliver Brüstle

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Cellular Reprogramming Using Protein and Cell-Penetrating Peptides.International journal of molecular sciences · 2017
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kristin StockInstitute of Reconstructive Neurobiology, LIFE and BRAIN Center, University of Bonn, Bonn, Germany.
Lars Nolden
Frank Edenhofer
Tamara Quandel
Oliver Brüstle
University of Bonn · DEHertie Foundation · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In contrast to conventional gene transfer strategies, the direct introduction of recombinant proteins into cells bypasses the risk of insertional mutagenesis and offers an alternative to genetic intervention. Here, we explore whether protein transduction of the gliogenic transcription factor Nkx2.2 can be used to promote oligodendroglial differentiation of mouse embryonic stem cell (ESC)-derived neural stem cells (NSC). To that end, a recombinant cell-permeant form of Nkx2.2 protein was generated. Exposure of ESC-derived NSC to the recombinant protein and initiation of differentiation resulted in a two-fold increase in the number of oligodendrocytes. Furthermore, Nkx2.2-transduced cells exhibited a more mature oligodendroglial phenotype. Comparative viral gene transfer studies showed that the biological effect of Nkx2.2 protein transduction is comparable to that obtained by lentiviral transduction. The results of this proof-of-concept study depict direct intracellular delivery of transcription factors as alternative modality to control lineage differentiation in NSC cultures without genetic modification.

Indexed as

Cell DifferentiationAnimalsBlotting, WesternCells, CulturedCell ShapeEmbryonic Stem CellsGenetic VectorsHomeobox Protein Nkx-2.2Homeodomain ProteinsHumansLentivirusMiceNuclear ProteinsOligodendrogliaPhenotypeRecombinant Fusion ProteinsHomeobox Protein Nkx-2.2Homeodomain Proteinsnkx2.2b protein, zebrafishNKX2-2 protein, humanNkx2-2 protein, mouseNuclear ProteinsRecombinant Fusion ProteinsTranscription FactorsZebrafish Proteins

Identifiers

PMID20352468
PMCPMC2889284
OpenAlexW1972792948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.